SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

TITAN BIOTECH

BSE: 524717 29 Sep 2025
Commodities
₹ 815.95
Titan Bio-Tech Ltd. specializes in Specialty Chemicals within the Commodities sector.

TITAN BIOTECH - Share Price & Details

Market Cap
₹746.0
High /Low
1,018 / 374.0
Stock P/E
33.9
Book Value
₹186.0
Dividend Yield
0.22
ROCE
16.9
ROE
₹15.0
Face Value
10.0
PEG Ratio
-147.0
EVEBITDA
₹24.8
Debt
2.80
CMP / FCF
70.2
Debt to equity
₹0.02
NP Ann
21.5
High price all time
1,018
Piotroski score
₹5.0
Graham Number
333.0
No. Eq. Shares
0.83
Net CF
₹2.29
Net profit
22.0
Price to book value
4.86
Interest Coverage
₹36.7
Low price all time
8.57
Industry PE
33.6
Reserves
₹145
Free Cash Flow
₹11.6

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
SOUTHERN GAS LTD.NANANANA0.060.03
INDO GULF INDUSTRIES LTD.NANANANA0
TITAN BIOTECH LTD.NANANANA746.033.9
INDO BORAX & CHEMICALS LTD.563.59100.35535.683.1374619.3
POCL ENTERPRISES LTDNANANANA72419.4

Peer Comparison Chart


About TITAN BIOTECH

Titan Bio-Tech Ltd., with Security Code 524717, is a leading player in the Specialty Chemicals industry, categorized under the Commodities sector, offering Equity instruments.


Order Book


Latest News

Titan Biotech's Quality Grade Change Reflects Strong Competitive Position in Specialty Chemicals

(27 Sep 2025)
Titan Biotech, a microcap in specialty chemicals, has shown significant sales growth of 10.56% over five years, despite a decline in EBIT.
Read more →

Titan Biotech Outshines Sensex with Exceptional Long-Term Performance Metrics

(20 Sep 2025)
Titan Biotech, a microcap in the specialty chemicals sector, has demonstrated impressive performance metrics, significantly outperforming the Sensex over...
Read more →

Taiwan Biotech Leader Joins Global Business Forum: Jyong CEO to Discuss Cross-Border Innovation

(18 Sep 2025)
Jyong Biotech CEO Fu Feng Kuo to discuss global biotech alignment at Taipei forum with US venture capital leaders.
Read more →

700+ Patient Milestone: Jyong Biotech's Prostate Cancer Prevention Drug Advances in Phase II Trial

(16 Sep 2025)
Taiwan-based Jyong Biotech completes enrollment of 700+ subjects for MCS-8 prostate cancer prevention trial across 20 hospitals.
Read more →

Asia-Pacific Yeast Extract Market to hit US$689.66 million

(15 Sep 2025)
"Asia-Pacific Yeast Extract Market reached US$372.60 million in 2024 and is expected to reach US$689.66 million by 2032, growing with a CAGR...
Read more →

Dividend Stocks: IGL, Dixon Tech, Mazagon Dock, among others to trade ex-dividend next week — Check details here

(14 Sep 2025)
Dividend Stocks: Companies including Indraprastha Gas (IGL), Dixon Tech, Mazagon Dock, Aarti Pharmalabs, Panasonic Energy India,...
Read more →